1. A bivalent vaccine containing glycosylated MUC-2-KLH and globo H-KLH conjugates using a new semi-synthetic saponin immunological adjuvant, GPI-0100, in biochemically relapsed prostate cancer (PC);Slovin;Proc Am Soc Clin Onc,2002
2. MUC-2-KLH conjugate vaccine: immunogenicity in patients with relapsed prostate cancer;Slovin;Proc Am Assoc Cancer Res,1999
3. Specificity analysis of sera from breast and prostate cancer patients vaccinated with MUC1-KLH and MUC-2-KLH conjugate vaccines;Ragupathi;Proc Am Assoc Cancer Res,1999
4. Carbohydrate vaccines in cancer: immunogenicity of a fully synthetic globo H hexasaccharide conjugate in man;Slovin;Proc Natl Acad Sci USA,1999
5. Peptide and carbohydrate vaccines in relapsed prostate cancer: immunogenicity of synthetic vaccines in man;Slovin;Sem Onc,1999